PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxd1
|
ENSMUSG00000078302.6 | Foxd1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxd1 | mm39_v1_chr13_+_98490742_98490758 | -0.12 | 3.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_162923474 | 23.09 |
ENSMUST00000073973.11
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr6_+_135339543 | 17.09 |
ENSMUST00000205156.3
|
Emp1
|
epithelial membrane protein 1 |
chr10_+_115653152 | 14.85 |
ENSMUST00000080630.11
ENSMUST00000179196.3 ENSMUST00000035563.15 |
Tspan8
|
tetraspanin 8 |
chr6_+_135339929 | 13.25 |
ENSMUST00000032330.16
|
Emp1
|
epithelial membrane protein 1 |
chr17_+_47816042 | 13.15 |
ENSMUST00000183044.8
ENSMUST00000037333.17 |
Ccnd3
|
cyclin D3 |
chr15_+_80507671 | 13.01 |
ENSMUST00000043149.9
|
Grap2
|
GRB2-related adaptor protein 2 |
chr5_-_138169509 | 12.47 |
ENSMUST00000153867.8
|
Mcm7
|
minichromosome maintenance complex component 7 |
chr17_+_47815968 | 12.43 |
ENSMUST00000182129.8
ENSMUST00000171031.8 |
Ccnd3
|
cyclin D3 |
chr17_+_47816074 | 12.26 |
ENSMUST00000183177.8
ENSMUST00000182848.8 |
Ccnd3
|
cyclin D3 |
chr10_+_96452860 | 12.15 |
ENSMUST00000038377.9
|
Btg1
|
BTG anti-proliferation factor 1 |
chr3_-_27208010 | 11.19 |
ENSMUST00000108300.8
ENSMUST00000108298.9 |
Ect2
|
ect2 oncogene |
chr3_-_27207993 | 11.12 |
ENSMUST00000176242.9
ENSMUST00000176780.8 |
Ect2
|
ect2 oncogene |
chr17_+_35413415 | 10.51 |
ENSMUST00000025262.6
ENSMUST00000173600.2 |
Ltb
|
lymphotoxin B |
chr11_+_3280401 | 10.01 |
ENSMUST00000045153.11
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1 |
chr5_-_138169253 | 9.98 |
ENSMUST00000139983.8
|
Mcm7
|
minichromosome maintenance complex component 7 |
chr17_+_47816137 | 9.76 |
ENSMUST00000182935.8
ENSMUST00000182506.8 |
Ccnd3
|
cyclin D3 |
chrX_+_35152460 | 9.61 |
ENSMUST00000033419.13
|
Dock11
|
dedicator of cytokinesis 11 |
chr5_+_31409021 | 8.86 |
ENSMUST00000054829.13
ENSMUST00000201625.4 ENSMUST00000201937.4 |
Krtcap3
|
keratinocyte associated protein 3 |
chr11_+_33996920 | 8.70 |
ENSMUST00000052413.12
|
Lcp2
|
lymphocyte cytosolic protein 2 |
chr11_+_3280771 | 8.44 |
ENSMUST00000136536.8
ENSMUST00000093399.11 |
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1 |
chr11_+_3282424 | 8.39 |
ENSMUST00000136474.2
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1 |
chr6_+_29853745 | 7.69 |
ENSMUST00000064872.13
ENSMUST00000152581.8 ENSMUST00000176265.8 ENSMUST00000154079.8 |
Ahcyl2
|
S-adenosylhomocysteine hydrolase-like 2 |
chr6_-_83513222 | 7.67 |
ENSMUST00000075161.12
|
Actg2
|
actin, gamma 2, smooth muscle, enteric |
chr17_+_47815998 | 7.54 |
ENSMUST00000183210.2
|
Ccnd3
|
cyclin D3 |
chr10_+_96453408 | 7.44 |
ENSMUST00000218953.2
|
Btg1
|
BTG anti-proliferation factor 1 |
chr1_-_45542442 | 7.40 |
ENSMUST00000086430.5
|
Col5a2
|
collagen, type V, alpha 2 |
chr3_+_96465265 | 7.40 |
ENSMUST00000074519.13
ENSMUST00000049093.8 |
Txnip
|
thioredoxin interacting protein |
chr11_+_33997114 | 7.31 |
ENSMUST00000109329.9
|
Lcp2
|
lymphocyte cytosolic protein 2 |
chr1_-_54965470 | 7.25 |
ENSMUST00000179030.8
ENSMUST00000044359.16 |
Ankrd44
|
ankyrin repeat domain 44 |
chr1_+_12788720 | 7.20 |
ENSMUST00000088585.10
|
Sulf1
|
sulfatase 1 |
chr11_+_96820220 | 6.96 |
ENSMUST00000062172.6
|
Prr15l
|
proline rich 15-like |
chr6_-_83513184 | 6.91 |
ENSMUST00000205926.2
|
Actg2
|
actin, gamma 2, smooth muscle, enteric |
chr15_+_35296237 | 6.77 |
ENSMUST00000022952.6
|
Osr2
|
odd-skipped related 2 |
chr19_-_41836514 | 6.77 |
ENSMUST00000059231.4
|
Frat2
|
frequently rearranged in advanced T cell lymphomas 2 |
chr3_-_27207931 | 6.58 |
ENSMUST00000175857.2
ENSMUST00000177055.8 ENSMUST00000176535.8 |
Ect2
|
ect2 oncogene |
chr4_+_11191726 | 6.55 |
ENSMUST00000029866.16
ENSMUST00000108324.4 |
Ccne2
|
cyclin E2 |
chr5_-_148988110 | 6.55 |
ENSMUST00000110505.8
|
Hmgb1
|
high mobility group box 1 |
chr7_+_110371811 | 6.53 |
ENSMUST00000005829.13
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr8_+_35274440 | 6.44 |
ENSMUST00000033930.5
|
Dusp4
|
dual specificity phosphatase 4 |
chr3_-_52012462 | 6.41 |
ENSMUST00000121440.4
|
Maml3
|
mastermind like transcriptional coactivator 3 |
chr15_-_97729341 | 6.20 |
ENSMUST00000079838.14
ENSMUST00000118294.8 |
Hdac7
|
histone deacetylase 7 |
chr11_+_96820091 | 6.14 |
ENSMUST00000054311.6
ENSMUST00000107636.4 |
Prr15l
|
proline rich 15-like |
chr17_-_71158703 | 6.13 |
ENSMUST00000166395.9
|
Tgif1
|
TGFB-induced factor homeobox 1 |
chr5_+_21577640 | 5.90 |
ENSMUST00000035799.6
|
Fgl2
|
fibrinogen-like protein 2 |
chr12_-_15866763 | 5.87 |
ENSMUST00000020922.8
ENSMUST00000221215.2 ENSMUST00000221518.2 |
Trib2
|
tribbles pseudokinase 2 |
chr11_-_102255999 | 5.87 |
ENSMUST00000006749.10
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr5_-_138169476 | 5.73 |
ENSMUST00000147920.2
|
Mcm7
|
minichromosome maintenance complex component 7 |
chr17_+_29712008 | 5.71 |
ENSMUST00000234665.2
|
Pim1
|
proviral integration site 1 |
chr4_+_11191354 | 5.71 |
ENSMUST00000170901.8
|
Ccne2
|
cyclin E2 |
chr7_-_83304698 | 5.67 |
ENSMUST00000145610.8
|
Il16
|
interleukin 16 |
chr18_-_47466378 | 5.56 |
ENSMUST00000126684.2
ENSMUST00000156422.8 |
Sema6a
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr7_-_29204812 | 5.56 |
ENSMUST00000183096.8
ENSMUST00000085809.11 |
Sipa1l3
|
signal-induced proliferation-associated 1 like 3 |
chr8_+_106785434 | 5.51 |
ENSMUST00000212742.2
ENSMUST00000211991.2 |
Nfatc3
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 |
chr2_-_59955995 | 5.50 |
ENSMUST00000112550.8
|
Baz2b
|
bromodomain adjacent to zinc finger domain, 2B |
chr2_+_112096154 | 5.48 |
ENSMUST00000110991.9
|
Slc12a6
|
solute carrier family 12, member 6 |
chr4_-_149760488 | 5.42 |
ENSMUST00000118704.8
|
Pik3cd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
chr9_+_96078340 | 5.26 |
ENSMUST00000034982.16
ENSMUST00000188008.7 ENSMUST00000188750.7 ENSMUST00000185644.7 |
Tfdp2
|
transcription factor Dp 2 |
chr13_+_55593116 | 5.12 |
ENSMUST00000001115.16
ENSMUST00000224995.2 ENSMUST00000225925.2 ENSMUST00000099482.5 ENSMUST00000224118.2 |
Grk6
|
G protein-coupled receptor kinase 6 |
chr6_-_148847854 | 5.12 |
ENSMUST00000139355.8
ENSMUST00000146457.2 ENSMUST00000054080.15 |
Sinhcaf
|
SIN3-HDAC complex associated factor |
chr4_+_132857816 | 5.10 |
ENSMUST00000084241.12
ENSMUST00000138831.2 |
Wasf2
|
WASP family, member 2 |
chr2_+_127967951 | 5.08 |
ENSMUST00000089634.12
ENSMUST00000019281.14 ENSMUST00000110341.9 ENSMUST00000103211.8 ENSMUST00000103210.2 |
Bcl2l11
|
BCL2-like 11 (apoptosis facilitator) |
chr11_-_54846873 | 5.08 |
ENSMUST00000155316.2
ENSMUST00000108889.10 ENSMUST00000126703.8 |
Tnip1
|
TNFAIP3 interacting protein 1 |
chr1_+_130793406 | 5.01 |
ENSMUST00000038829.7
|
Fcmr
|
Fc fragment of IgM receptor |
chr14_-_68893253 | 4.82 |
ENSMUST00000225767.3
ENSMUST00000111072.8 ENSMUST00000022642.6 ENSMUST00000224039.2 |
Adam28
|
a disintegrin and metallopeptidase domain 28 |
chr3_-_129834788 | 4.78 |
ENSMUST00000168644.3
|
Sec24b
|
Sec24 related gene family, member B (S. cerevisiae) |
chr17_+_23879448 | 4.75 |
ENSMUST00000062967.10
|
Bicdl2
|
BICD family like cargo adaptor 2 |
chr12_+_71063431 | 4.73 |
ENSMUST00000125125.2
|
Arid4a
|
AT rich interactive domain 4A (RBP1-like) |
chr15_+_61857226 | 4.64 |
ENSMUST00000161976.8
ENSMUST00000022971.8 |
Myc
|
myelocytomatosis oncogene |
chr5_-_136595205 | 4.61 |
ENSMUST00000176778.8
|
Cux1
|
cut-like homeobox 1 |
chr11_-_101117237 | 4.54 |
ENSMUST00000100417.3
ENSMUST00000107285.8 ENSMUST00000107284.8 |
Ezh1
|
enhancer of zeste 1 polycomb repressive complex 2 subunit |
chr8_-_85705338 | 4.49 |
ENSMUST00000064922.7
|
Junb
|
jun B proto-oncogene |
chr19_+_56414114 | 4.48 |
ENSMUST00000238892.2
|
Casp7
|
caspase 7 |
chr16_+_24266829 | 4.48 |
ENSMUST00000078988.10
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma |
chr19_+_58748132 | 4.36 |
ENSMUST00000026081.5
|
Pnliprp2
|
pancreatic lipase-related protein 2 |
chr1_-_69726384 | 4.34 |
ENSMUST00000187184.7
|
Ikzf2
|
IKAROS family zinc finger 2 |
chr6_+_54658609 | 4.28 |
ENSMUST00000190641.7
ENSMUST00000187701.2 |
Mturn
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
chr15_-_98816012 | 4.27 |
ENSMUST00000023736.10
|
Lmbr1l
|
limb region 1 like |
chr6_+_30541581 | 4.26 |
ENSMUST00000096066.5
|
Cpa2
|
carboxypeptidase A2, pancreatic |
chr5_-_148988413 | 4.22 |
ENSMUST00000093196.11
|
Hmgb1
|
high mobility group box 1 |
chr12_+_112645237 | 4.10 |
ENSMUST00000174780.2
ENSMUST00000169593.2 ENSMUST00000173942.2 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr18_-_80751327 | 4.09 |
ENSMUST00000236310.2
ENSMUST00000167977.8 ENSMUST00000035800.8 |
Nfatc1
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
chr1_+_173501215 | 4.02 |
ENSMUST00000085876.12
|
Ifi208
|
interferon activated gene 208 |
chr10_-_4338032 | 4.02 |
ENSMUST00000100078.10
|
Zbtb2
|
zinc finger and BTB domain containing 2 |
chr4_-_138452517 | 4.02 |
ENSMUST00000105811.9
|
Ubxn10
|
UBX domain protein 10 |
chr15_+_61857390 | 4.02 |
ENSMUST00000159327.2
ENSMUST00000167731.8 |
Myc
|
myelocytomatosis oncogene |
chr12_-_32000534 | 3.98 |
ENSMUST00000172314.9
|
Hbp1
|
high mobility group box transcription factor 1 |
chr19_-_7319157 | 3.98 |
ENSMUST00000164205.8
ENSMUST00000165286.8 ENSMUST00000168324.2 ENSMUST00000032557.15 |
Mark2
|
MAP/microtubule affinity regulating kinase 2 |
chr19_-_27988393 | 3.96 |
ENSMUST00000172907.8
ENSMUST00000046898.17 |
Rfx3
|
regulatory factor X, 3 (influences HLA class II expression) |
chr11_-_74480870 | 3.91 |
ENSMUST00000145524.2
ENSMUST00000102521.9 |
Rap1gap2
|
RAP1 GTPase activating protein 2 |
chr3_+_138566249 | 3.88 |
ENSMUST00000121826.3
|
Tspan5
|
tetraspanin 5 |
chr3_-_92922976 | 3.84 |
ENSMUST00000107301.2
ENSMUST00000029521.5 |
Crct1
|
cysteine-rich C-terminal 1 |
chr2_-_163486998 | 3.76 |
ENSMUST00000017851.4
|
Serinc3
|
serine incorporator 3 |
chr3_-_143910926 | 3.76 |
ENSMUST00000120539.8
ENSMUST00000196264.5 |
Lmo4
|
LIM domain only 4 |
chr19_+_7534838 | 3.75 |
ENSMUST00000141887.8
ENSMUST00000136756.2 |
Plaat3
|
phospholipase A and acyltransferase 3 |
chr2_+_18069375 | 3.75 |
ENSMUST00000114671.8
ENSMUST00000114680.9 |
Mllt10
|
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10 |
chr15_+_79232137 | 3.72 |
ENSMUST00000163691.3
|
Maff
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) |
chr19_+_45433899 | 3.71 |
ENSMUST00000224478.2
|
Btrc
|
beta-transducin repeat containing protein |
chr2_+_112114906 | 3.68 |
ENSMUST00000053666.8
|
Slc12a6
|
solute carrier family 12, member 6 |
chr6_+_142244145 | 3.67 |
ENSMUST00000041993.3
|
Iapp
|
islet amyloid polypeptide |
chr6_+_34840057 | 3.66 |
ENSMUST00000074949.4
|
Tmem140
|
transmembrane protein 140 |
chr1_-_64995982 | 3.65 |
ENSMUST00000097713.2
|
Plekhm3
|
pleckstrin homology domain containing, family M, member 3 |
chr13_+_55357585 | 3.63 |
ENSMUST00000224973.2
ENSMUST00000099490.3 |
Nsd1
|
nuclear receptor-binding SET-domain protein 1 |
chr3_-_51248032 | 3.61 |
ENSMUST00000062009.14
ENSMUST00000194641.6 |
Elf2
|
E74-like factor 2 |
chr3_-_133250889 | 3.60 |
ENSMUST00000197118.5
|
Tet2
|
tet methylcytosine dioxygenase 2 |
chr19_-_7318798 | 3.57 |
ENSMUST00000165965.8
ENSMUST00000051711.16 ENSMUST00000169541.8 ENSMUST00000165989.2 |
Mark2
|
MAP/microtubule affinity regulating kinase 2 |
chr16_-_4376471 | 3.56 |
ENSMUST00000230875.2
|
Tfap4
|
transcription factor AP4 |
chr9_+_96078299 | 3.52 |
ENSMUST00000165120.9
|
Tfdp2
|
transcription factor Dp 2 |
chr6_-_148847633 | 3.46 |
ENSMUST00000132696.8
|
Sinhcaf
|
SIN3-HDAC complex associated factor |
chr19_+_53317844 | 3.41 |
ENSMUST00000111737.3
ENSMUST00000025998.15 ENSMUST00000237837.2 |
Mxi1
|
MAX interactor 1, dimerization protein |
chr10_+_101994841 | 3.39 |
ENSMUST00000020039.13
|
Mgat4c
|
MGAT4 family, member C |
chr19_+_41818409 | 3.39 |
ENSMUST00000087155.5
|
Frat1
|
frequently rearranged in advanced T cell lymphomas |
chr18_+_69652837 | 3.36 |
ENSMUST00000201410.4
ENSMUST00000202937.4 |
Tcf4
|
transcription factor 4 |
chr3_-_143908111 | 3.36 |
ENSMUST00000121796.8
|
Lmo4
|
LIM domain only 4 |
chr15_-_51855073 | 3.36 |
ENSMUST00000022927.11
|
Rad21
|
RAD21 cohesin complex component |
chr15_+_79231720 | 3.35 |
ENSMUST00000096350.11
|
Maff
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) |
chr1_+_36550948 | 3.33 |
ENSMUST00000001166.14
ENSMUST00000097776.4 |
Cnnm3
|
cyclin M3 |
chr7_-_25488060 | 3.31 |
ENSMUST00000002677.11
ENSMUST00000085948.11 |
Axl
|
AXL receptor tyrosine kinase |
chr11_+_120123727 | 3.30 |
ENSMUST00000122148.8
ENSMUST00000044985.14 |
Bahcc1
|
BAH domain and coiled-coil containing 1 |
chr8_+_70826191 | 3.28 |
ENSMUST00000003659.9
|
Comp
|
cartilage oligomeric matrix protein |
chr10_-_26249952 | 3.28 |
ENSMUST00000105519.10
ENSMUST00000040219.13 |
L3mbtl3
|
L3MBTL3 histone methyl-lysine binding protein |
chr19_+_34268071 | 3.25 |
ENSMUST00000112472.4
ENSMUST00000235232.2 |
Fas
|
Fas (TNF receptor superfamily member 6) |
chr3_-_143908060 | 3.24 |
ENSMUST00000121112.6
|
Lmo4
|
LIM domain only 4 |
chr10_+_59942274 | 3.14 |
ENSMUST00000165024.3
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr12_-_100691316 | 3.12 |
ENSMUST00000222731.2
|
Rps6ka5
|
ribosomal protein S6 kinase, polypeptide 5 |
chr3_+_102965910 | 3.12 |
ENSMUST00000199367.5
ENSMUST00000199049.5 ENSMUST00000197678.5 |
Nras
|
neuroblastoma ras oncogene |
chr19_+_36325683 | 3.11 |
ENSMUST00000225920.2
|
Pcgf5
|
polycomb group ring finger 5 |
chr9_+_13298301 | 3.08 |
ENSMUST00000159294.9
|
Maml2
|
mastermind like transcriptional coactivator 2 |
chr19_+_7534816 | 3.08 |
ENSMUST00000136465.8
ENSMUST00000025925.11 |
Plaat3
|
phospholipase A and acyltransferase 3 |
chr6_-_124888643 | 3.06 |
ENSMUST00000032217.2
|
Lag3
|
lymphocyte-activation gene 3 |
chr4_+_101365144 | 3.04 |
ENSMUST00000149047.8
ENSMUST00000106929.10 |
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chr13_-_98951890 | 3.04 |
ENSMUST00000040340.16
ENSMUST00000179563.8 ENSMUST00000109403.2 |
Fcho2
|
FCH domain only 2 |
chr7_+_112806672 | 3.03 |
ENSMUST00000047321.9
ENSMUST00000210074.2 ENSMUST00000210238.2 |
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr9_+_78522783 | 3.01 |
ENSMUST00000093812.5
|
Cd109
|
CD109 antigen |
chr9_+_45281483 | 2.99 |
ENSMUST00000085939.8
ENSMUST00000217381.2 |
Fxyd6
|
FXYD domain-containing ion transport regulator 6 |
chr15_-_58187556 | 2.93 |
ENSMUST00000022985.2
|
Klhl38
|
kelch-like 38 |
chr19_+_5927821 | 2.88 |
ENSMUST00000145200.8
ENSMUST00000025732.14 ENSMUST00000125114.8 ENSMUST00000155697.8 |
Slc25a45
|
solute carrier family 25, member 45 |
chr3_-_30067285 | 2.83 |
ENSMUST00000172694.8
|
Mecom
|
MDS1 and EVI1 complex locus |
chr7_+_90075762 | 2.82 |
ENSMUST00000061391.9
|
Ccdc89
|
coiled-coil domain containing 89 |
chr10_+_101994719 | 2.81 |
ENSMUST00000138522.8
ENSMUST00000163753.8 ENSMUST00000138016.8 |
Mgat4c
|
MGAT4 family, member C |
chr5_-_142803405 | 2.80 |
ENSMUST00000151477.8
|
Tnrc18
|
trinucleotide repeat containing 18 |
chr9_+_56982622 | 2.80 |
ENSMUST00000167715.8
|
Sin3a
|
transcriptional regulator, SIN3A (yeast) |
chr1_+_40720731 | 2.75 |
ENSMUST00000192345.2
|
Slc9a2
|
solute carrier family 9 (sodium/hydrogen exchanger), member 2 |
chr7_+_126359869 | 2.71 |
ENSMUST00000206272.2
|
Mapk3
|
mitogen-activated protein kinase 3 |
chr5_-_73789764 | 2.65 |
ENSMUST00000087177.4
|
Lrrc66
|
leucine rich repeat containing 66 |
chr6_-_13677928 | 2.63 |
ENSMUST00000203078.2
ENSMUST00000045235.8 |
Bmt2
|
base methyltransferase of 25S rRNA 2 |
chr14_-_54651442 | 2.61 |
ENSMUST00000227334.2
|
Slc7a7
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
chr8_+_66070661 | 2.59 |
ENSMUST00000110258.8
ENSMUST00000110256.8 ENSMUST00000110255.8 |
Marchf1
|
membrane associated ring-CH-type finger 1 |
chr3_-_30067537 | 2.59 |
ENSMUST00000108270.10
|
Mecom
|
MDS1 and EVI1 complex locus |
chr6_+_15185202 | 2.53 |
ENSMUST00000154448.2
|
Foxp2
|
forkhead box P2 |
chr5_-_137530214 | 2.50 |
ENSMUST00000140139.2
|
Gnb2
|
guanine nucleotide binding protein (G protein), beta 2 |
chr7_+_24607042 | 2.46 |
ENSMUST00000151121.2
|
Arhgef1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
chr19_+_5927876 | 2.44 |
ENSMUST00000235340.2
|
Slc25a45
|
solute carrier family 25, member 45 |
chr14_-_110992533 | 2.44 |
ENSMUST00000078386.4
|
Slitrk6
|
SLIT and NTRK-like family, member 6 |
chr11_+_107438751 | 2.43 |
ENSMUST00000100305.8
ENSMUST00000075012.8 ENSMUST00000106746.8 |
Helz
|
helicase with zinc finger domain |
chr5_-_123127346 | 2.41 |
ENSMUST00000118027.8
|
Kdm2b
|
lysine (K)-specific demethylase 2B |
chr7_-_141614758 | 2.40 |
ENSMUST00000211000.2
ENSMUST00000209725.2 ENSMUST00000084418.4 |
Mob2
|
MOB kinase activator 2 |
chr10_+_21758083 | 2.37 |
ENSMUST00000120509.8
|
Sgk1
|
serum/glucocorticoid regulated kinase 1 |
chr4_+_32238950 | 2.33 |
ENSMUST00000037416.13
|
Bach2
|
BTB and CNC homology, basic leucine zipper transcription factor 2 |
chr12_-_86125793 | 2.32 |
ENSMUST00000003687.8
|
Tgfb3
|
transforming growth factor, beta 3 |
chr19_-_29721012 | 2.30 |
ENSMUST00000175764.9
|
9930021J03Rik
|
RIKEN cDNA 9930021J03 gene |
chr2_+_181479647 | 2.23 |
ENSMUST00000029116.14
ENSMUST00000108754.8 |
Pcmtd2
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 |
chr3_-_37286714 | 2.21 |
ENSMUST00000161015.2
ENSMUST00000029273.8 |
Il21
|
interleukin 21 |
chr4_-_108690741 | 2.20 |
ENSMUST00000102740.8
ENSMUST00000102741.8 |
Btf3l4
|
basic transcription factor 3-like 4 |
chr4_-_128699838 | 2.17 |
ENSMUST00000106072.9
ENSMUST00000170934.3 |
Zfp362
|
zinc finger protein 362 |
chr1_-_154692678 | 2.13 |
ENSMUST00000238369.2
|
Cacna1e
|
calcium channel, voltage-dependent, R type, alpha 1E subunit |
chr8_-_35962641 | 2.13 |
ENSMUST00000033927.8
|
Eri1
|
exoribonuclease 1 |
chr17_-_66191912 | 2.12 |
ENSMUST00000024905.11
|
Ralbp1
|
ralA binding protein 1 |
chr9_+_7272514 | 2.11 |
ENSMUST00000015394.10
|
Mmp13
|
matrix metallopeptidase 13 |
chr1_+_179373935 | 2.09 |
ENSMUST00000040706.9
|
Cnst
|
consortin, connexin sorting protein |
chr7_+_126359763 | 2.05 |
ENSMUST00000091328.4
|
Mapk3
|
mitogen-activated protein kinase 3 |
chr5_+_25451771 | 2.05 |
ENSMUST00000144971.2
|
Galnt11
|
polypeptide N-acetylgalactosaminyltransferase 11 |
chr19_-_7319211 | 2.04 |
ENSMUST00000171393.8
|
Mark2
|
MAP/microtubule affinity regulating kinase 2 |
chr4_+_94627513 | 2.02 |
ENSMUST00000073939.13
ENSMUST00000102798.8 |
Tek
|
TEK receptor tyrosine kinase |
chr5_+_86952072 | 2.02 |
ENSMUST00000119339.8
ENSMUST00000120498.8 |
Ythdc1
|
YTH domain containing 1 |
chr7_-_141614590 | 2.01 |
ENSMUST00000211206.2
|
Mob2
|
MOB kinase activator 2 |
chr11_+_101623776 | 2.00 |
ENSMUST00000039152.14
|
Dhx8
|
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
chr10_-_93146825 | 1.97 |
ENSMUST00000151153.2
|
Elk3
|
ELK3, member of ETS oncogene family |
chr15_+_25752963 | 1.96 |
ENSMUST00000022882.12
ENSMUST00000135173.8 |
Myo10
|
myosin X |
chr3_+_32490525 | 1.95 |
ENSMUST00000108242.2
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
chr4_+_65042411 | 1.95 |
ENSMUST00000084501.4
|
Pappa
|
pregnancy-associated plasma protein A |
chr12_-_100691251 | 1.95 |
ENSMUST00000043599.7
|
Rps6ka5
|
ribosomal protein S6 kinase, polypeptide 5 |
chr11_-_102446947 | 1.91 |
ENSMUST00000143842.2
|
Gpatch8
|
G patch domain containing 8 |
chr3_+_52175757 | 1.90 |
ENSMUST00000053764.7
|
Foxo1
|
forkhead box O1 |
chr2_-_84652890 | 1.85 |
ENSMUST00000028471.6
|
Smtnl1
|
smoothelin-like 1 |
chr12_+_84463970 | 1.85 |
ENSMUST00000183146.2
|
Rnf113a2
|
ring finger protein 113A2 |
chr13_+_42454922 | 1.84 |
ENSMUST00000021796.9
|
Edn1
|
endothelin 1 |
chr16_-_78887971 | 1.83 |
ENSMUST00000023566.11
ENSMUST00000060402.6 |
Tmprss15
|
transmembrane protease, serine 15 |
chr4_-_59549243 | 1.83 |
ENSMUST00000173699.8
ENSMUST00000173884.8 ENSMUST00000102883.11 ENSMUST00000174586.8 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr7_-_143239600 | 1.83 |
ENSMUST00000208017.2
ENSMUST00000152703.2 |
Tnfrsf23
|
tumor necrosis factor receptor superfamily, member 23 |
chr14_-_71004019 | 1.83 |
ENSMUST00000167242.8
|
Xpo7
|
exportin 7 |
chr5_-_147244074 | 1.83 |
ENSMUST00000031650.4
|
Cdx2
|
caudal type homeobox 2 |
chr4_+_101365052 | 1.82 |
ENSMUST00000038207.12
|
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chr5_+_3978266 | 1.81 |
ENSMUST00000044492.10
|
Akap9
|
A kinase (PRKA) anchor protein (yotiao) 9 |
chr4_+_138452593 | 1.79 |
ENSMUST00000124660.7
ENSMUST00000030530.6 |
Pla2g2c
|
phospholipase A2, group IIC |
chr16_+_25105560 | 1.78 |
ENSMUST00000056087.4
|
Tprg
|
transformation related protein 63 regulated |
chr18_+_69652550 | 1.78 |
ENSMUST00000201205.4
|
Tcf4
|
transcription factor 4 |
chr3_-_146475974 | 1.77 |
ENSMUST00000106137.8
|
Prkacb
|
protein kinase, cAMP dependent, catalytic, beta |
chr17_-_48189815 | 1.76 |
ENSMUST00000154108.2
|
Foxp4
|
forkhead box P4 |
chr4_-_129534403 | 1.75 |
ENSMUST00000084264.12
|
Txlna
|
taxilin alpha |
chr11_+_96024612 | 1.71 |
ENSMUST00000167258.8
|
Ttll6
|
tubulin tyrosine ligase-like family, member 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 23.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
3.6 | 10.8 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
2.7 | 24.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.4 | 26.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.3 | 28.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
2.3 | 9.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
2.2 | 8.7 | GO:0046722 | lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
2.1 | 55.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.0 | 5.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.9 | 7.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.7 | 5.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
1.4 | 28.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.4 | 4.1 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
1.4 | 6.8 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.2 | 7.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
1.2 | 4.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.2 | 4.8 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
1.2 | 10.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.1 | 3.3 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
1.1 | 3.2 | GO:0031104 | dendrite regeneration(GO:0031104) |
1.1 | 3.2 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
1.0 | 4.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.0 | 5.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.0 | 30.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.9 | 3.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.9 | 4.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.9 | 7.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.8 | 4.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.8 | 2.4 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.8 | 2.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.8 | 3.8 | GO:0009597 | detection of virus(GO:0009597) |
0.7 | 9.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 | 2.8 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.7 | 2.8 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.7 | 5.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.7 | 3.3 | GO:0097350 | dendritic cell apoptotic process(GO:0097048) neutrophil clearance(GO:0097350) regulation of dendritic cell apoptotic process(GO:2000668) |
0.7 | 6.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 9.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 1.8 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.6 | 3.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.6 | 4.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 5.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.5 | 1.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.5 | 6.9 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 2.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 2.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.5 | 10.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.5 | 4.7 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
0.5 | 7.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 3.7 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 1.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 2.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.4 | 1.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 2.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 3.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 1.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.4 | 1.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.4 | 2.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.4 | 6.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 1.5 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 1.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.3 | 12.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 5.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 7.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 4.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 2.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 4.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 4.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 5.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 1.0 | GO:2000850 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 2.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 5.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 3.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 3.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 6.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.9 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.3 | 4.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 7.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 4.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 1.4 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.3 | 1.1 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.3 | 1.9 | GO:0071455 | response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.3 | 2.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 7.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 1.8 | GO:0043144 | snoRNA processing(GO:0043144) |
0.3 | 3.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 2.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 5.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 5.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 3.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 2.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.7 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.2 | 6.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 1.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.2 | 1.7 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.2 | 1.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 5.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 1.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 2.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 1.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 2.1 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.2 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 1.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 5.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 16.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 9.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 1.5 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.2 | 1.5 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 5.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 1.0 | GO:1900740 | positive regulation of thymocyte apoptotic process(GO:0070245) regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 1.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 4.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 3.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 5.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 3.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 3.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 2.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 8.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 2.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.7 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 5.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 3.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0097273 | creatinine homeostasis(GO:0097273) cellular ammonia homeostasis(GO:0097275) cellular creatinine homeostasis(GO:0097276) cellular urea homeostasis(GO:0097277) |
0.1 | 2.8 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.1 | 0.2 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.1 | 1.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 1.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 2.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 1.9 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 2.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 1.8 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 1.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 2.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 1.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 3.0 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 1.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 1.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 14.5 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 1.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 4.0 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 2.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.7 | GO:0036398 | TCR signalosome(GO:0036398) |
4.8 | 28.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
4.1 | 12.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
2.5 | 7.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.8 | 28.2 | GO:0042555 | MCM complex(GO:0042555) |
1.1 | 3.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.9 | 4.5 | GO:0035976 | AP1 complex(GO:0035976) |
0.8 | 55.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 9.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 2.7 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.6 | 6.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 5.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 3.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.5 | 2.3 | GO:0044307 | dendritic branch(GO:0044307) |
0.4 | 5.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 3.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 5.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 2.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 4.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 1.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 4.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.7 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 4.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 8.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 5.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 4.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 2.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 1.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 12.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 3.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 1.0 | GO:0031673 | H zone(GO:0031673) |
0.1 | 2.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.6 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 4.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 5.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 7.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 4.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 7.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 1.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 15.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 19.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 10.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 3.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 25.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 3.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 60.7 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 3.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.8 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 1.9 | GO:0031430 | M band(GO:0031430) |
0.0 | 9.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 8.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 13.0 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 2.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 2.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 1.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 2.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 4.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 26.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
3.8 | 23.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
3.6 | 10.8 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
2.3 | 9.2 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
2.1 | 6.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.1 | 7.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.0 | 7.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 5.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.0 | 55.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.8 | 4.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.8 | 3.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 8.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.7 | 6.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 28.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.6 | 6.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 9.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 2.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.5 | 1.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 3.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.5 | 3.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 7.8 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.5 | 5.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 4.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 2.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 5.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 3.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 3.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 2.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 4.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 2.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.3 | 12.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 6.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 13.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 3.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 2.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.3 | 4.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 5.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 6.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 1.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 1.3 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.3 | 4.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 40.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 14.2 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 6.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 2.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 1.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 2.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 2.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 2.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 3.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 1.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.1 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 1.7 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 7.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 2.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 12.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 2.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.1 | 2.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 2.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 1.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 5.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 2.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 3.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 2.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 8.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 11.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 4.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 3.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 3.8 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 3.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 3.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 1.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 3.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 1.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 13.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 7.9 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 7.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 4.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 10.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 16.0 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.0 | 2.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 1.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 1.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 2.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 1.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 1.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.0 | GO:0051117 | ATPase binding(GO:0051117) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 29.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.9 | 67.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 12.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 10.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 30.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 24.6 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 3.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 5.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 14.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 10.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 5.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 20.7 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 12.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 14.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 5.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 5.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 6.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 7.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 13.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 3.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 5.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 3.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 6.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 9.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 9.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 29.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.2 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 14.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 9.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 2.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 28.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 55.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 10.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 11.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.7 | 29.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 19.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 10.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 9.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.5 | 7.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 9.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 4.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 28.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 6.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 11.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 4.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 6.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 12.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 6.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 5.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 3.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 3.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 7.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 5.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 5.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 4.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 3.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 8.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 4.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 3.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 6.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 3.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 6.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 6.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 2.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 11.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 2.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 3.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 4.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 2.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 2.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |